CN110101753A - 一种复方灵芝提取物组合物的制备方法和用途 - Google Patents
一种复方灵芝提取物组合物的制备方法和用途 Download PDFInfo
- Publication number
- CN110101753A CN110101753A CN201910407813.5A CN201910407813A CN110101753A CN 110101753 A CN110101753 A CN 110101753A CN 201910407813 A CN201910407813 A CN 201910407813A CN 110101753 A CN110101753 A CN 110101753A
- Authority
- CN
- China
- Prior art keywords
- powder
- parts
- seed
- alcohol
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 241000222336 Ganoderma Species 0.000 title claims abstract description 74
- 239000000203 mixture Substances 0.000 title claims abstract description 69
- 150000001875 compounds Chemical class 0.000 title claims abstract description 63
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 240000002924 Platycladus orientalis Species 0.000 claims abstract description 57
- 239000003814 drug Substances 0.000 claims abstract description 55
- 210000000582 semen Anatomy 0.000 claims abstract description 55
- 244000292697 Polygonum aviculare Species 0.000 claims abstract description 52
- 235000006386 Polygonum aviculare Nutrition 0.000 claims abstract description 52
- 240000008397 Ganoderma lucidum Species 0.000 claims abstract description 46
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims abstract description 46
- 239000000463 material Substances 0.000 claims abstract description 34
- 229920000858 Cyclodextrin Polymers 0.000 claims abstract description 27
- 238000000034 method Methods 0.000 claims abstract description 26
- 235000014101 wine Nutrition 0.000 claims abstract description 26
- 239000003826 tablet Substances 0.000 claims abstract description 18
- 239000002775 capsule Substances 0.000 claims abstract description 17
- 239000006187 pill Substances 0.000 claims abstract description 17
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 235000013376 functional food Nutrition 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 229940100688 oral solution Drugs 0.000 claims abstract description 6
- 239000000843 powder Substances 0.000 claims description 90
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 70
- 238000002386 leaching Methods 0.000 claims description 44
- 239000012141 concentrate Substances 0.000 claims description 33
- 239000007788 liquid Substances 0.000 claims description 32
- 238000002156 mixing Methods 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 238000010438 heat treatment Methods 0.000 claims description 22
- 238000007654 immersion Methods 0.000 claims description 22
- 238000003756 stirring Methods 0.000 claims description 19
- 229940079593 drug Drugs 0.000 claims description 17
- 229940023488 pill Drugs 0.000 claims description 16
- 238000000227 grinding Methods 0.000 claims description 15
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 11
- 230000005484 gravity Effects 0.000 claims description 11
- 239000008187 granular material Substances 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 8
- 239000001116 FEMA 4028 Substances 0.000 claims description 7
- 229960004853 betadex Drugs 0.000 claims description 7
- 239000007938 effervescent tablet Substances 0.000 claims description 7
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 6
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 6
- 240000006365 Vitis vinifera Species 0.000 claims description 6
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 6
- 235000020097 white wine Nutrition 0.000 claims description 5
- 229940126678 chinese medicines Drugs 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 4
- 239000002893 slag Substances 0.000 claims description 4
- 238000002791 soaking Methods 0.000 claims description 4
- 238000001291 vacuum drying Methods 0.000 claims description 4
- 235000013405 beer Nutrition 0.000 claims description 3
- 239000006189 buccal tablet Substances 0.000 claims description 3
- 229940046011 buccal tablet Drugs 0.000 claims description 3
- 239000007910 chewable tablet Substances 0.000 claims description 3
- 235000019991 rice wine Nutrition 0.000 claims description 3
- PCWPQSDFNIFUPO-VDQKLNDWSA-N (1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31S,33R,35R,36R,37S,38R,39S,40R,41S,42R,43S,44R,45S,46R,47S,48R,49S)-37,39,41,43,45,47,49-heptakis(2-hydroxyethoxy)-5,10,15,20,25,30,35-heptakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,38,40,42,44,46,48-heptol Chemical compound OCCO[C@H]1[C@H](O)[C@@H]2O[C@H]3O[C@H](CO)[C@@H](O[C@H]4O[C@H](CO)[C@@H](O[C@H]5O[C@H](CO)[C@@H](O[C@H]6O[C@H](CO)[C@@H](O[C@H]7O[C@H](CO)[C@@H](O[C@H]8O[C@H](CO)[C@@H](O[C@H]1O[C@@H]2CO)[C@@H](O)[C@@H]8OCCO)[C@@H](O)[C@@H]7OCCO)[C@@H](O)[C@@H]6OCCO)[C@@H](O)[C@@H]5OCCO)[C@@H](O)[C@@H]4OCCO)[C@@H](O)[C@@H]3OCCO PCWPQSDFNIFUPO-VDQKLNDWSA-N 0.000 claims description 2
- QGKBSGBYSPTPKJ-UZMKXNTCSA-N 2,6-di-o-methyl-β-cyclodextrin Chemical compound COC[C@H]([C@H]([C@@H]([C@H]1OC)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COC)[C@H]([C@@H]([C@H]3OC)O)O[C@H]3O[C@H](COC)[C@H]([C@@H]([C@H]3OC)O)O[C@H]3O[C@H](COC)[C@H]([C@@H]([C@H]3OC)O)O[C@H]3O[C@H](COC)[C@H]([C@@H]([C@H]3OC)O)O3)[C@H](O)[C@H]2OC)COC)O[C@@H]1O[C@H]1[C@H](O)[C@@H](OC)[C@@H]3O[C@@H]1COC QGKBSGBYSPTPKJ-UZMKXNTCSA-N 0.000 claims description 2
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 2
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 2
- 239000007902 hard capsule Substances 0.000 claims description 2
- 239000008188 pellet Substances 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 claims description 2
- 244000061520 Angelica archangelica Species 0.000 claims 3
- 229940097346 sulfobutylether-beta-cyclodextrin Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 210000002216 heart Anatomy 0.000 description 45
- 239000008280 blood Substances 0.000 description 33
- 210000004369 blood Anatomy 0.000 description 30
- 235000008504 concentrate Nutrition 0.000 description 24
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 20
- 206010022437 insomnia Diseases 0.000 description 20
- 239000000047 product Substances 0.000 description 20
- 230000007812 deficiency Effects 0.000 description 17
- 210000003734 kidney Anatomy 0.000 description 17
- 235000009508 confectionery Nutrition 0.000 description 16
- 239000000796 flavoring agent Substances 0.000 description 14
- 235000019634 flavors Nutrition 0.000 description 14
- 210000004185 liver Anatomy 0.000 description 14
- 239000003643 water by type Substances 0.000 description 14
- 230000007958 sleep Effects 0.000 description 13
- 206010033557 Palpitations Diseases 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 230000008569 process Effects 0.000 description 9
- 240000002045 Guettarda speciosa Species 0.000 description 8
- 241000345998 Calamus manan Species 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 235000012950 rattan cane Nutrition 0.000 description 7
- 208000000044 Amnesia Diseases 0.000 description 6
- 208000031091 Amnestic disease Diseases 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 6
- 230000006986 amnesia Effects 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 230000015556 catabolic process Effects 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 230000036565 night sweats Effects 0.000 description 5
- 206010029410 night sweats Diseases 0.000 description 5
- 230000001624 sedative effect Effects 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 229920001353 Dextrin Polymers 0.000 description 4
- 239000004375 Dextrin Substances 0.000 description 4
- 206010036790 Productive cough Diseases 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 208000031971 Yin Deficiency Diseases 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 235000019425 dextrin Nutrition 0.000 description 4
- 239000000932 sedative agent Substances 0.000 description 4
- 230000003860 sleep quality Effects 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 230000002936 tranquilizing effect Effects 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 3
- 206010067482 No adverse event Diseases 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- 208000001431 Psychomotor Agitation Diseases 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000001147 anti-toxic effect Effects 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000013872 defecation Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 229940069328 povidone Drugs 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241000218691 Cupressaceae Species 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 244000000231 Sesamum indicum Species 0.000 description 2
- 235000003434 Sesamum indicum Nutrition 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 239000005864 Sulphur Substances 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 235000020374 simple syrup Nutrition 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 229960004793 sucrose Drugs 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- YZOUYRAONFXZSI-SBHWVFSVSA-N (1S,3R,5R,6R,8R,10R,11R,13R,15R,16R,18R,20R,21R,23R,25R,26R,28R,30R,31S,33R,35R,36R,37S,38R,39S,40R,41S,42R,43S,44R,45S,46R,47S,48R,49S)-5,10,15,20,25,30,35-heptakis(hydroxymethyl)-37,39,40,41,42,43,44,45,46,47,48,49-dodecamethoxy-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,38-diol Chemical compound O([C@@H]([C@H]([C@@H]1OC)OC)O[C@H]2[C@@H](O)[C@@H]([C@@H](O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3O)OC)O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3OC)OC)O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3OC)OC)O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3OC)OC)O3)O[C@@H]2CO)OC)[C@H](CO)[C@H]1O[C@@H]1[C@@H](OC)[C@H](OC)[C@H]3[C@@H](CO)O1 YZOUYRAONFXZSI-SBHWVFSVSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000382455 Angelica sinensis Species 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000218645 Cedrus Species 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 241001289529 Fallopia multiflora Species 0.000 description 1
- 241001489091 Ganoderma sinense Species 0.000 description 1
- 241000146384 Glaux Species 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 241000208966 Polygala Species 0.000 description 1
- 241001080798 Polygala tenuifolia Species 0.000 description 1
- 241000205407 Polygonum Species 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- 241000612118 Samolus valerandi Species 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 208000031320 Teratogenesis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- ODLHGICHYURWBS-FOSILIAISA-N molport-023-220-444 Chemical compound CC(O)COC[C@@H]([C@@H]([C@H]([C@@H]1O)O)O[C@@H]2O[C@H]([C@H](O[C@@H]3O[C@@H](COCC(C)O)[C@@H]([C@H]([C@@H]3O)O)O[C@@H]3O[C@@H](COCC(C)O)[C@@H]([C@H]([C@@H]3O)O)O[C@@H]3O[C@@H](COCC(C)O)[C@@H]([C@H]([C@@H]3O)O)O[C@@H]3O[C@@H](COCC(C)O)[C@@H]([C@H]([C@@H]3O)O)O3)[C@@H](O)[C@@H]2O)COCC(O)C)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O)[C@H]3O[C@H]1COCC(C)O ODLHGICHYURWBS-FOSILIAISA-N 0.000 description 1
- 231100000150 mutagenicity / genotoxicity testing Toxicity 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000036578 sleeping time Effects 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000011122 softwood Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000020985 whole grains Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
- C12G1/00—Preparation of wine or sparkling wine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
- C12G3/00—Preparation of other alcoholic beverages
- C12G3/04—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs
- C12G3/05—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs with health-improving ingredients, e.g. flavonoids, flavones, polyphenols or polysaccharides
- C12G3/055—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs with health-improving ingredients, e.g. flavonoids, flavones, polyphenols or polysaccharides extracted from plants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Reproductive Health (AREA)
- Inorganic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
Abstract
本发明属于中药加工领域,涉及功能性食品领域。具体涉及一种复方灵芝提取物组合物的制备方法和用途。本发明一种复方灵芝提取物组合物的制备方法,它是由以下重量份的中药原料灵芝9‑12,首乌藤5‑8,制远志7‑10,当归5‑8,酸枣仁9‑12,柏子仁5‑8和与中药材原料等重量份的环糊精制成。本发明制备的复方灵芝提取物组合物按常规工艺制成片剂、胶囊剂、丸剂、口服液作为制备功能性食品或酒品的用途。
Description
技术领域
本发明属于中药提取物及提取物加工利用领域,具体涉及一种复方灵芝提取物组合物的制备方法和用途。
背景技术
由于现代人们生活节奏加快,生活压力大,生活结构的变化,生活中一些特有疾病也相应地呈现增多趋势。如常因压力大,造成身心疲惫,心悸怔忡,失眠多梦,精神焦虑,神经衰弱等,给人们的身心健康带来一定的影响。心藏神,肝藏魂,人体的精神、意识、思维活动,与心、肝二脉密切相关。《素问·举痛论》云:“惊则心无所依,神无所归,虚无所定,故气乱矣。”《景岳全书》云:“无邪而不寐者,必营气不足也,营主血,血虚则无以养心,心虚则神不守舍。”说明心神受扰或心神失养,均会导致心神不宁病症,出现心烦失眠,健忘多梦,心悸怔忡等神识异常的症状。
本发明利用中医药中具有养心安神的中药材,组成药用组合,该组合具虑证心神不安,应选用养心安神之药物,若血虚阴亏者,须与补血,养阴药物配伍;心脾两虚者,则与补益心脾药配伍;心肾不交者,又与滋阴降火,交通心肾之品配伍的理念,形成含有灵芝、首乌藤、制远志、当归、酸枣仁、柏子仁等药物组合。该养心安神药物组合中的酸枣仁、制远志等亦具有不同程度的中枢抑制作用,酸枣仁、灵芝等对非特异性免疫和特异性免疫具有增强作用。酸枣仁、制远志、灵芝对心血管系统尚有抗心肌缺血的作用。就灵芝、首乌藤、制远志、当归、酸枣仁、柏子仁诸药材组合制备的提取物组合物以及该组合物在功能性食品中的应用,经检索,目前尚未有相关专利申请。
发明内容
本发明的目的在于提供一种复方灵芝提取物组合物的制备方法,本发明的目的还在于提供该复方灵芝提取物组合物作为制备功能性食品或酒品的用途。
本发明提供的一种复方灵芝提取物组合物的制备方法,其特征在于,它是由以下重量份的中药原料灵芝9-12份,首乌藤5-8份,制远志7-10份,当归5-8份,酸枣仁9-12份,柏子仁5-8份和与中药材原料等重量份的环糊精制成,
其制备方法如下:(1)首先分别将中药材灵芝、首乌藤、制远志、当归、酸枣仁、柏子仁进行烘干,称取灵芝、首乌藤、制远志、当归粉碎成50目粉,称取酸枣仁、柏子仁粉碎成80目粉备用;(2)将灵芝粉、首乌藤粉、制远志粉、当归粉混合均匀后,加入到中药材总重量比例为1:10浓度为75%v/v的酒精中,常温浸泡12天,滤取浸泡酒精液保存备用,滤渣备用;(3)取酸枣仁粉、柏子仁粉混合均匀后,加入到中药材总重量比例为1:10浓度为99%v/v的酒精中,常温浸泡12天,浸泡期间每天搅拌一次,浸泡结束后,滤取酒精浸泡液保存备用,滤渣备用;(4)将步骤(2)和(3)所得酒精浸泡液分别回收酒精后,得浓缩液混合备用;(5)将步骤(2)和(3)中的滤渣合并,加入原材料重量比例为1:10的水,混合均匀,加热煮沸2小时,滤取煎煮液,将药渣再加入原药材重量比例为1:8的水,加热煮沸1.5小时,滤取煎煮液,弃去滤渣;(6)将步骤(5)两次煎煮液合并,经过滤,浓缩,浓缩至比重至5.0得浓缩液备用;(7)将步骤(6)所得浓缩液与步骤(4)所得混合浓缩液合并,按中药材等重量份加入环糊精,置于球磨机内充分研磨2.5小时,研磨结束后,取出物料,经干燥至含水量在5-6%/w、碾碎,过80目筛,即得复方灵芝提取物组合物。
本发明上述所述的环糊精(CYD),可以是β-环糊精(β-CYD),也可以是2,6-二甲基-β-环糊精(DM-β--CYD)、羟乙基-β-环糊精(HE-β-CYD)、羟丙基-β-环糊精(HP-β-CYD)和磺丁基醚-β-环糊精(SBE-β-CYD)中的任意一种。
CYD安全无毒,根据世界卫生组织对食品添加剂的有关规定(FAQ营养学会议NO46WHO/FOOD ADD/70.36),酶化学特征的淀粉无需再做毒性研究;许多试验研究也证明β-CYD具有很高的安全性,急性毒性试验显示小鼠口服其LD50>300 mg/kg,急性毒性和慢性毒性试验,致畸致癌、致突变试验等证明了本品使用安全无毒。美国、日本的药典己将β-CYD收载为口服辅料:HP-B-CYD(羟丙基-B-环糊精)已被美国药典和Wade A编著的《Handboofk ofPharrnaceutical Excipients》收载为注射用辅料(赵浩如等主编,现代中药制剂新技术,江苏科学技术出版社,2007年2月第1版,151页)。
本发明所述的酒精,在没有作出特定说明时,均为食用级酒精。
本发明中所述的水,在没有特定说明时,均为纯化水。
本发明上述所述的干燥,为采用真空干燥,其真空干燥的条件为温度50℃、真空度为0.2kPa。
本发明所述的复方灵芝提取物组合物按常规工艺作为制成片剂、胶囊剂、颗粒剂、丸剂、口服液作为制备功能性食品的用途。
所述的复方灵芝提取物组合物作为制备酒制品的用途。
本发明优选的一种复方灵芝提取物组合物的制备方法,其特征是由以下重量份的中药原料灵芝10-11份,首乌藤6-7份,制远志8-9份,当归6-7份,酸枣仁10-11份,柏子仁6-7份和与中药材原料等重量份的环糊精制成。
本发明进一步优选的一种复方灵芝提取物组合物的制备方法,其特征是由以下重量份的中药原料灵芝10.5份,首乌藤6.5份,制远志8.5份,当归6.5份,酸枣仁10.5份,柏子仁6.5份和与中药材原料等重量份的环糊精制成。
灵芝为多孔菌科真菌赤芝Ganoderma Lucidum(Leyss.ex Fr.) Karst·或紫芝Ganoderma sinense zhao,xu et zhang的干燥子实体。性味甘、平。归心、肺、肝、肾经。具有补气安神,止咳平喘功能。用于心神不宁,失眠心悸,肺虚咳喘,虚劳短气,不思饮食。
效用分析:灵芝味甘能补,入心经,能益心气,安心神,故可用治心神失养所致心神不宁,失眠,惊悸等。灵芝又入肺肾二经,补益肺肾之气,止咳嗽,平喘息,常可用治肺虚咳喘,虚劳短气,不思饮食等。
灵芝配酸枣仁,灵芝补气安神,酸枣仁养血安神。两药同用,益气补血安神,用于气血不足,心神失养所致失眠多梦之症(《中国药典》·临床用药须知·中药饮片卷,2015年版,1004-1005页)。
首乌藤为蓼科植物何首乌Polygonum mulii florum Thunb.的干燥藤茎。性味甘,平。归心、肝经。具养血安神,祛风通络功能。用于失眠多梦,血虚身痛,风湿痹痛,皮肤瘙痒。
效用分析:首乌藤味甘而补,入心、肝经,能养心血,安心神,适用于阴虚血少之心神不宁,失眠多梦等。
配伍应用:首乌藤配柏子仁、远志,首乌藤、柏子仁养血宁心;远志化痰安神。三药相伍,化痰安神,适用于痰浊上扰所致的心神不安,惊悸失眠症。首乌藤配酸枣仁,两者皆能养血安神,配用则增强安神之效,适用于血虚失眠,多梦而易醒者(《中国药典》·临床用药须知·中药饮片卷,2015年版,1011页)。
远志为远志科植物制远志Polygala tenuifolia Willd.或卵叶远志Polygalasibirica L.的干燥根。性味苦、辛,温。归心、肾、肺经。具安神益智,交通心肾,祛痰,消肿功能。用于心肾不交引起的失眠多梦,健忘惊悸,神志恍惚,咳痰不爽,疮疡肿毒,乳房肿痛。
效用分析:远志苦辛性温,入心、肾经。能开心气、通肾气,为交通心肾,安神定志之要药,适用于心肾不交,心神不宁,失眠多梦,健忘惊悸,神志恍惚(《中国药典》·临床用药须知·中药饮片卷,2015年版,1014-1015页)。
制远志炮制,取甘草煎汤,与净远志共煮至汤吸尽,干燥。鉴别应用:远志与制远志,二者均为远志的不同炮制品种,由于炮制方法不同,作用亦各有偏重。远志能安神益智、交通心肾、祛痰、消肿,用于心肾不交引起的失眠多梦、健忘惊悸、神志恍惚,咳痰不爽,疮疡肿毒,乳房肿痛。而制远志既能缓和燥性,又能消除麻味,防止刺喉,以安神益智为主,多用于心神不安,惊悸,失眠,健忘。
当归为伞形科植物当归Angelica sinensis(Oliv.) Diels的干燥根。性味甘、辛,温。归肝、心、脾经。具补血活血,调经止痛,润肠通便功能。用于血虚萎黄,眩晕心悸,月经不调,经闭痛经,虚寒腹痛,风湿痹痛,跌扑损伤,痈疽疮疡,肠燥便秘等。
效用分析:当归味甘、辛而性温,入肝、心、脾经。心主血,肝藏血,脾统血。其甘润以补血,辛散温通以活血,善能补血,又能活血,“成为血中之气药,亦血中之圣药”。当归甘温,养血补虚,为补血良药,故可用治心肝血虚,面色萎黄,眩晕心悸。使用安神药时,若血虚阴亏者则宜与补血、养阴药配伍,当归在本发明中作为辅药应用。
酸枣仁为鼠李科植物酸枣Ziziphus jujuba Mill.var.spinosa(Bunge)Hu etH.F.chou的干燥成熟种子。性味甘、酸,平。归肝、胆、心经。具养心补肝,宁心安神,敛汗,生津功能。用于虚烦不眠,惊悸多梦,体虚多汗,津伤口渴。
效用分析:酸枣仁味甘能补,入肝、心二经,有养心阴、益肝血而宁心安神之效,为养心安神要药,主治心肝阴血不足、心失所养,神不守舍所致心悸怔忡,虚烦不眠,多梦等。
酸枣仁味酸能敛,有收敛止汗之效,用治体虚多汗,盗汗;并有酸甘化阴、生津止渴之功,可用治津伤口渴咽干之症。
配伍应用:酸枣仁配柏子仁,酸枣仁甘酸性平,补肝养心,宁心安神,益阴敛汗;柏子仁质地滋润,甘平入心,养血宁神,又有润肠之功。两药合用,补肝养心,用于心肝血虚,怔忡,惊悸,失眠,多汗,便秘等(《中国药典》·临床用药须知·中药饮片卷,2015年版,1000-1001页)。
柏子仁为柏科植物侧柏Platycladus Orientalis(L.)Franco的干燥成熟种仁。性味甘,平。归心、肾、大肠经。具养心安神,润肠通便,止汗功能。用于阴血不足,虚烦失眠,心悸怔忡,肠燥便秘,阴虚盗汗等症。
效用分析:柏子仁味甘质润,药性平和,主入心经,有养心安神之功。主要用于心阴不足,心血亏虚所致的虚烦失眠,心悸怔忡等。柏子仁质润多脂,有润肠通便之功,可用于阴虚血亏,老年、产后等肠燥便秘。柏子仁甘润,又能止汗,多用治阴虚盗汗。
鉴别应用:柏子仁与酸枣仁,二者皆味甘性平,入心经,有养心安神之效,用治阴血不足,心神失养所致的心悸怔忡、失眠健忘等,常相须为用。柏子仁质润多脂,能润肠通便而治疗肠燥便秘。酸枣仁安神作用较强,且味酸收敛止汗作用好,体虚自汗,盗汗常选用(《中国药典》·临床用药须知·中药饮片卷,2015年版,1003-1004页)。
本发明养心安神中药组合物多有甘润滋养之性,故有滋养心肝、益阴补血、交通心肾等作用,主要适用于阴血不足、心脾两虚、心肾不交等导致的心悸、怔仲、虚烦不眠、健忘多梦、遗精、盗汗等。
利用本发明上述中药组合,利用现代加工工艺制备成提取物组合物,不仅可以作为功能性食品内服食用或饮用,还可以根据需要配制成不同的口服剂型。可以将中药提取物组合物与药学上或食品上可以接受的辅料混合配制成颗粒剂,片剂,胶囊,丸剂,口服液,酒制品等;其中片剂优选泡腾片、咀嚼片、口含片,因泡腾片、咀嚼片、口含片与普通片剂相比有以下几点明显优势:(1)服用方便,可嚼服、含服,可化水,由于配制这些片剂都要加入一定量的糖粉作为赋形剂,因而口感好,人们乐意服用,泡腾片加水自溶后犹如一杯饮料,使人们乐于饮用;(2)吸收快,生物利用度高;(3)便于携带,方便运输;(4)易于量化,用量相应准确;其中胶囊剂可制备成软胶囊剂和硬胶囊剂,其中丸剂可制备成水泛丸、滴丸、微丸和蜜丸;其中所述的酒制品可选用现有的白酒、葡萄酒、黄酒和啤酒,经勾兑、陈化制备成白酒、葡萄酒、黄酒和啤酒制品。
具体实施方式
通过以下实施例是对本发明作进一步的说明,但对本发明的范围不构成任何限制。
实施例1
一种复方灵芝提取物组合物的制备
(1)首先取中药材灵芝、首乌藤、制远志、当归、酸枣仁、柏子仁分别进行烘干,称取灵芝900克、首乌藤500克、制远志700克、当归500克,酸枣仁900克,柏子仁500克,将灵芝、首乌藤、制远志、当归粉碎成50目粉,酸枣仁、柏子仁粉碎成80目粉备用;(2)将灵芝粉、首乌藤粉、制远志粉、当归粉混合均匀后,加入到26000克浓度为75%v/v的食用酒精中,常温浸泡12天,滤取浸泡酒精液,滤渣备用;(3)取酸枣仁粉、柏子仁粉混合均匀后,加入到14000克浓度为99%v/v的食用酒精中,常温浸泡12天,浸泡期间每天搅拌1次,浸泡结束后,滤取酒精浸泡液,滤渣备用;(4)将步骤(2)和(3)所得酒精浸泡液分别回收酒精后,将浓缩液混合,得混合浓缩液备用;(5)将步骤(2)和(3)中的滤渣合并,加入到40000克纯化水中,搅拌均匀,加热煮沸2小时,滤取煎煮液,滤渣再加入32000克纯化水,加热煮沸1.5小时,滤取煎煮液,弃去滤渣;(6)将步骤(5)两次煎煮液合并,经过滤,浓缩,浓缩至比重为5.0时停止浓缩,得浓缩液备用;(7)将步骤(6)所得浓缩液与步骤(4)所得混合浓缩液合并,加入4000克β-环糊精,置于球磨机内充分研磨2.5小时,研磨结束后,取出物料,置入真空干燥机内,在温度为50℃、真空度为0.2kPa条件下干燥至物料含水量在5%,取出放冷后,碾碎,过80目筛,即得复方灵芝提取物组合物。
所述的复方灵芝提取物组合物按常规工艺制成片剂、胶囊剂、颗粒剂、丸剂或口服液作为制备功能性食品的用途。所述的复方灵芝提取物组合物按公知工艺进行勾兑、陈化作为制备酒品的用途。
实施例2
一种复方灵芝提取物组合物的制备
(1)首先取中药材灵芝、首乌藤、制远志、当归、酸枣仁、柏子仁分别进行烘干,称取灵芝1200克、首乌藤800克、制远志1000克、当归800克,酸枣仁1200克,柏子仁800克,将灵芝、首乌藤、制远志、当归粉碎成50目粉,酸枣仁、柏子仁粉碎成80目粉备用;(2)将灵芝粉、首乌藤粉、制远志粉、当归粉混合均匀后,加入到38000克浓度为75%v/v的食用酒精中,常温浸泡12天,滤取浸泡酒精液,滤渣备用;(3)取酸枣仁粉、柏子仁粉混合均匀后,加入到20000克浓度为99%v/v的食用酒精中,常温浸泡12天,浸泡期间每天搅拌1次,浸泡结束后,滤取酒精浸泡液,滤渣备用;(4)将步骤(2)和(3)所得酒精浸泡液分别回收酒精后,将浓缩液混合,得混合浓缩液备用;(5)将步骤(2)和(3)中的滤渣合并,加入到58000克纯化水中,搅拌均匀,加热煮沸2小时,滤取煎煮液,滤渣再加入46400克纯化水,加热煮沸1.5小时,滤取煎煮液,弃去滤渣;(6)将步骤(5)两次煎煮液合并,经过滤,浓缩,浓缩至比重为5.0时停止浓缩,得浓缩液备用;(7)将步骤(6)所得浓缩液与步骤(4)所得混合浓缩液合并,加入5800克羟乙基-β-环糊精,置于球磨机内充分研磨2.5小时,研磨结束后,取出物料,置入真空干燥机内,在温度为50℃、真空度为0.2kPa条件下干燥至物料含水量在6%,取出放冷后,碾碎,过80目筛,即得复方灵芝提取物组合物。
所述的复方灵芝提取物组合物按常规工艺制成片剂、胶囊剂、颗粒剂、丸剂或口服液作为制备功能性食品的用途。所述的复方灵芝提取物组合物按公知工艺进行勾兑、陈化作为制备酒品的用途。
实施例3
一种复方灵芝提取物组合物的制备
(1)首先取中药材灵芝、首乌藤、制远志、当归、酸枣仁、柏子仁分别进行烘干,称取灵芝1000克、首乌藤600克、制远志800克、当归600克,酸枣仁1000克,柏子仁600克,将灵芝、首乌藤、制远志、当归粉碎成50目粉,酸枣仁、柏子仁粉碎成80目粉备用;(2)将灵芝粉、首乌藤粉、制远志粉、当归粉混合均匀后,加入到30000克浓度为75%v/v的食用酒精中,常温浸泡12天,滤取浸泡酒精液,滤渣备用;(3)取酸枣仁粉、柏子仁粉混合均匀后,加入到16000克浓度为99%v/v的食用酒精中,常温浸泡12天,浸泡期间每天搅拌1次,浸泡结束后,滤取酒精浸泡液,滤渣备用;(4)将步骤(2)和(3)所得酒精浸泡液分别回收酒精后,将浓缩液混合,得混合浓缩液备用;(5)将步骤(2)和(3)中的滤渣合并,加入到46000克纯化水中,搅拌均匀,加热煮沸2小时,滤取煎煮液,滤渣再加入36800克纯化水,加热煮沸1.5小时,滤取煎煮液,弃去滤渣;(6)将步骤(5)两次煎煮液合并,经过滤,浓缩,浓缩至比重为5.0时停止浓缩,得浓缩液备用;(7)将步骤(6)所得浓缩液与步骤(4)所得混合浓缩液合并,加入4600克2,6-二甲基-β-环糊精,置于球磨机内充分研磨2.5小时,研磨结束后,取出物料,置入真空干燥机内,在温度为50℃、真空度为0.2kPa条件下干燥至物料含水量在5.5%,取出放冷后,碾碎,过80目筛,即得复方灵芝提取物组合物。
所述的复方灵芝提取物组合物按常规工艺制成片剂、胶囊剂、颗粒剂、丸剂或口服液作为制备功能性食品的用途。所述的复方灵芝提取物组合物按公知工艺进行勾兑、陈化作为制备酒品的用途。
实施例4
一种复方灵芝提取物组合物的制备
(1)首先取中药材灵芝、首乌藤、制远志、当归、酸枣仁、柏子仁分别进行烘干,称取灵芝1050克、首乌藤650克、制远志850克、当归650克,酸枣仁1050克,柏子仁650克,将灵芝、首乌藤、制远志、当归粉碎成50目粉,酸枣仁、柏子仁粉碎成80目粉备用;(2)将灵芝粉、首乌藤粉、制远志粉、当归粉混合均匀后,加入到32000克浓度为75%v/v的食用酒精中,常温浸泡12天,滤取浸泡酒精液,滤渣备用;(3)取酸枣仁粉、柏子仁粉混合均匀后,加入到17000克浓度为99%v/v的食用酒精中,常温浸泡12天,浸泡期间每天搅拌1次,浸泡结束后,滤取酒精浸泡液,滤渣备用;(4)将步骤(2)和(3)所得酒精浸泡液分别回收酒精后,将浓缩液混合,得混合浓缩液备用;(5)将步骤(2)和(3)中的滤渣合并,加入到49000克纯化水中,搅拌均匀,加热煮沸2小时,滤取煎煮液,滤渣再加入39200克纯化水,加热煮沸1.5小时,滤取煎煮液,弃去滤渣;(6)将步骤(5)两次煎煮液合并,经过滤,浓缩,浓缩至比重为5.0时停止浓缩,得浓缩液备用;(7)将步骤(6)所得浓缩液与步骤(4)所得混合浓缩液合并,加入4900克磺丁基醚-β-环糊精,置于球磨机内充分研磨2.5小时,研磨结束后,取出物料,置入真空干燥机内,在温度为50℃、真空度为0.2kPa条件下干燥至物料含水量在5.3%,取出放冷后,碾碎,过80目筛,即得复方灵芝提取物组合物。
所述的复方灵芝提取物组合物按常规工艺制成片剂、胶囊剂、颗粒剂、丸剂或口服液作为制备功能性食品的用途。所述的复方灵芝提取物组合物按公知工艺进行勾兑、陈化作为制备酒品的用途。
实施例5
一种复方灵芝提取物组合物的制备
(1)首先取中药材灵芝、首乌藤、制远志、当归、酸枣仁、柏子仁分别进行烘干,称取灵芝1100克、首乌藤700克、制远志900克、当归700克,酸枣仁1100克,柏子仁700克,将灵芝、首乌藤、制远志、当归粉碎成50目粉,酸枣仁、柏子仁粉碎成80目粉备用;(2)将灵芝粉、首乌藤粉、制远志粉、当归粉混合均匀后,加入到34000克浓度为75%v/v的食用酒精中,常温浸泡12天,滤取浸泡酒精液,滤渣备用;(3)取酸枣仁粉、柏子仁粉混合均匀后,加入到18000克浓度为99%v/v的食用酒精中,常温浸泡12天,浸泡期间每天搅拌1次,浸泡结束后,滤取酒精浸泡液,滤渣备用;(4)将步骤(2)和(3)所得酒精浸泡液分别回收酒精后,将浓缩液混合,得混合浓缩液备用;(5)将步骤(2)和(3)中的滤渣合并,加入到52000克纯化水中,搅拌均匀,加热煮沸2小时,滤取煎煮液,滤渣再加入41600克纯化水,加热煮沸1.5小时,滤取煎煮液,弃去滤渣;(6)将步骤(5)两次煎煮液合并,经过滤,浓缩,浓缩至比重为5.0时停止浓缩,得浓缩液备用;(7)将步骤(6)所得浓缩液与步骤(4)所得混合浓缩液合并,加入5200克羟丙基-β-环糊精,置于球磨机内充分研磨2.5小时,研磨结束后,取出物料,置入真空干燥机内,在温度为50℃、真空度为0.2kPa条件下干燥至物料含水量在5.8%,取出放冷后,碾碎,过80目筛,即得复方灵芝提取物组合物。
所述的复方灵芝提取物组合物按常规工艺制成片剂、胶囊剂、颗粒剂、丸剂或口服液作为制备功能性食品的用途。所述的复方灵芝提取物组合物按公知工艺进行勾兑、陈化作为制备酒品的用途。
实施例6
一种复方灵芝提取物组合物的制备
(1)首先取中药材灵芝、首乌藤、制远志、当归、酸枣仁、柏子仁分别进行烘干,称取灵芝1100克、首乌藤600克、制远志900克、当归600克,酸枣仁1000克,柏子仁600克,将灵芝、首乌藤、制远志、当归粉碎成50目粉,酸枣仁、柏子仁粉碎成80目粉备用;(2)将灵芝粉、首乌藤粉、制远志粉、当归粉混合均匀后,加入到32000克浓度为75%v/v的食用酒精中,常温浸泡12天,滤取浸泡酒精液,滤渣备用;(3)取酸枣仁粉、柏子仁粉混合均匀后,加入到16000克浓度为99%v/v的食用酒精中,常温浸泡12天,浸泡期间每天搅拌1次,浸泡结束后,滤取酒精浸泡液,滤渣备用;(4)将步骤(2)和(3)所得酒精浸泡液分别回收酒精后,将浓缩液混合,得混合浓缩液备用;(5)将步骤(2)和(3)中的滤渣合并,加入到48000克纯化水中,搅拌均匀,加热煮沸2小时,滤取煎煮液,滤渣再加入38400克纯化水,加热煮沸1.5小时,滤取煎煮液,弃去滤渣;(6)将步骤(5)两次煎煮液合并,经过滤,浓缩,浓缩至比重为5.0时停止浓缩,得浓缩液备用;(7)将步骤(6)所得浓缩液与步骤(4)所得混合浓缩液合并,加入4800克β-环糊精,置于球磨机内充分研磨2.5小时,研磨结束后,取出物料,置入真空干燥机内,在温度为50℃、真空度为0.2kPa条件下干燥至物料含水量在5.2%,取出放冷后,碾碎,过80目筛,即得复方灵芝提取物组合物。
所述的复方灵芝提取物组合物按常规工艺制成片剂、胶囊剂、颗粒剂、丸剂或口服液作为制备功能性食品的用途。所述的复方灵芝提取物组合物按公知工艺进行勾兑、陈化作为制备酒品的用途。
实施例7
一种复方灵芝提取物组合物的制备
(1)首先取中药材灵芝、首乌藤、制远志、当归、酸枣仁、柏子仁分别进行烘干,称取灵芝1000克、首乌藤700克、制远志700克、当归500克,酸枣仁900克,柏子仁800克,将灵芝、首乌藤、制远志、当归粉碎成50目粉,酸枣仁、柏子仁粉碎成80目粉备用;(2)将灵芝粉、首乌藤粉、制远志粉、当归粉混合均匀后,加入到29000克浓度为75%v/v的食用酒精中,常温浸泡12天,滤取浸泡酒精液,滤渣备用;(3)取酸枣仁粉、柏子仁粉混合均匀后,加入到17000克浓度为99%v/v的食用酒精中,常温浸泡12天,浸泡期间每天搅拌1次,浸泡结束后,滤取酒精浸泡液,滤渣备用;(4)将步骤(2)和(3)所得酒精浸泡液分别回收酒精后,将浓缩液混合,得混合浓缩液备用;(5)将步骤(2)和(3)中的滤渣合并,加入到46000克纯化水中,搅拌均匀,加热煮沸2小时,滤取煎煮液,滤渣再加入36800克纯化水,加热煮沸1.5小时,滤取煎煮液,弃去滤渣;(6)将步骤(5)两次煎煮液合并,经过滤,浓缩,浓缩至比重为5.0时停止浓缩,得浓缩液备用;(7)将步骤(6)所得浓缩液与步骤(4)所得混合浓缩液合并,加入4600克羟丙基-β-环糊精,置于球磨机内充分研磨2.5小时,研磨结束后,取出物料,置入真空干燥机内,在温度为50℃、真空度为0.2kPa条件下干燥至物料含水量在6%,取出放冷后,碾碎,过80目筛,即得复方灵芝提取物组合物。
所述的复方灵芝提取物组合物按常规工艺制成片剂、胶囊剂、颗粒剂、丸剂或口服液作为制备功能性食品的用途。所述的复方灵芝提取物组合物按公知工艺进行勾兑、陈化作为制备酒品的用途。
应用实施例
实施例8
可按常规方式生产含有下列组分的片剂:
组分:
称取实施例1所得复方灵芝提取物组合物 100g
硬脂酸镁 20g
淀粉 380g
按常规方法制成片剂1000片,每片片重为0.5g。
实施例9
可按常规方式生产含有下列组分的胶囊剂:
组分:
称取实施例2所得复方灵芝提取物组合物 100g
糊精 80g
羧甲基纤维素钠 30g
淀粉 90g
将糊精、羧甲基纤维素钠和淀粉混合,经120℃干燥处理后,与复方灵芝提取物组合物混合均匀,过100目筛三次,使之充分均匀后,分别装入胶囊中,制得1000粒胶囊,每粒胶囊含量为0.3g。
实施例10
可按常规方式生产含有下列组分的泡腾片:
组分:
称取实施例3所得复方灵芝提取物组合物 200g
枸橼酸 600g
碳酸氢钠 1100g
乳糖 300g
糊精 300g
蔗糖粉 600g
聚维酮 100g
将复方灵芝提取物组合物和枸橼酸、碳酸氢钠、乳糖、糊精、蔗糖粉分别过100目尼龙筛。然后以等量递加的方法混合后再过100目尼龙筛,并充分混合,另取聚维酮加入适量乙醇使成含量为重量5%的聚维酮乙醇溶液,制软材,以20目尼龙筛制粒,经45℃烘干,整粒,加入适量聚乙二醇6000作为润滑剂,压片,制成泡腾片2000粒,每粒重量为1.6g。
实施例11
可按常规方式生产含有下列组分的口服液:
组分:
称取实施例7所得复方灵芝提取物组合物 50g
单糖浆 50g
蜂蜜 50g
柠檬酸 10g
纯净水 加至 1000g
取复方灵芝提取物组合物、柠檬酸、单糖浆、和蜂蜜分别依次加入适量的纯净水中使溶,然后再加纯净水至1000g,经过滤,分装于容量为10g小瓶中,经封口,采用100℃流通蒸汽灭菌30分钟,制成规格为复方灵芝提取物组合物为0.5g/10g的口服液。
实施例12
可按常规方式生产含有下列组分的酒:
组分:
称取实施例3所得复方灵芝提取物组合物 200g
50度白酒 4800g
称取复方灵芝提取物组合物加入50度白酒中,充分搅拌,然后放置室温处,密闭陈化15天后,过滤,分装,即得。
实施例13
可按常规方式生产含有下列组分的酒:
组分:
称取实施例6所得复方灵芝提取物组合物 30g
葡萄酒 970g
称取复方灵芝提取物组合物加入到配方量的现有葡萄酒中,搅拌均匀,密闭,置于3-5℃环境下,静置存放7天后,过滤,装瓶,封口即得。
本发明复方灵芝提取物组合物,在用于中老年人失眠的人群中,取得较好的调节睡眠的应用效果。6例50-55岁女性中老年人,每天晚饭后服用本发明实施例13制得的葡萄酒产品,每次服用量20ml,较服药前每夜晚睡眠不足4小时,延时睡眠至7-8小时,6例志愿者服用产品后,均感夜间睡眠较深,无不良反应。选择10例60-65岁有饮酒习惯的老年男性,每晚睡觉前60分钟饮用本发明实施例12制得的白酒产品30-50ml不等,结果除1例因前列腺炎病痛夜间反复醒起外,其余9例老人均睡眠6-8小时,且睡眠质量良好,无不良反应。4例22-26岁女性青年,因工作压力较大,长期失眠有50余天,精神状态较差,对4位病例均给予本发明实施例10制得的泡腾片,每次两片,于睡前30分钟将药片溶于适量水中内服,结果1例服用产品三天后,夜晚睡眠可达5-6小时,且睡眠质量良好,其中3例均在用药6天后,睡眠质量得以改善,每天睡眠时间可达6小时以上,且睡眠质量良好,4例病例服用产品一个月后,停止用药,无不良反应,晚间能正常入睡,白天精神状态良好,工作精力充沛,停用产品两个月后,无失眠反复现象。
Claims (10)
1.一种复方灵芝提取物组合物的制备方法,其特征在于,它是由以下重量份的中药原料灵芝9-12份,首乌藤5-8份,制远志7-10份,当归5-8份,酸枣仁9-12份,柏子仁5-8份和与中药材原料等重量份的环糊精制成,
其制备方法如下:(1)首先分别将中药材灵芝、首乌藤、制远志、当归、酸枣仁、柏子仁进行烘干,称取灵芝、首乌藤、制远志、当归粉碎成50目粉,称取酸枣仁、柏子仁粉碎成80目粉备用;(2)将灵芝粉、首乌藤粉、制远志粉、当归粉混合均匀后,加入到中药材总重量比例为1:10浓度为75%v/v的酒精中,常温浸泡12天,滤取浸泡酒精液保存备用,滤渣备用;(3)取酸枣仁粉、柏子仁粉混合均匀后,加入到中药材总重量比例为1:10浓度为99%v/v的酒精中,常温浸泡12天,浸泡期间每天搅拌一次,浸泡结束后,滤取酒精浸泡液保存备用,滤渣备用;(4)将步骤(2)和(3)所得酒精浸泡液分别回收酒精后,得浓缩液混合备用;(5)将步骤(2)和(3)中的滤渣合并,加入原材料重量比例为1:10的水,混合均匀,加热煮沸2小时,滤取煎煮液,将药渣再加入原药材重量比例为1:8的水,加热煮沸1.5小时,滤取煎煮液,弃去滤渣;(6)将步骤(5)两次煎煮液合并,经过滤,浓缩,浓缩至比重至5.0得浓缩液备用;(7)将步骤(6)所得浓缩液与步骤(4)所得混合浓缩液合并,按中药材等重量份加入环糊精,置于球磨机内充分研磨2.5小时,研磨结束后,取出物料,经干燥至含水量在5-6%/w、碾碎,过80目筛,即得复方灵芝提取物组合物。
2.一种复方灵芝提取物组合物的制备方法,其特征在于,它是由以下重量份的中药原料灵芝10-11份,首乌藤6-7份,制远志8-9份,当归6-7份,酸枣仁10-11份,柏子仁6-7份和与中药材原料等重量份的环糊精制成,
其制备方法如下:(1)首先分别将中药材灵芝、首乌藤、制远志、当归、酸枣仁、柏子仁进行烘干,称取灵芝、首乌藤、制远志、当归粉碎成50目粉,称取酸枣仁、柏子仁粉碎成80目粉备用;(2)将灵芝粉、首乌藤粉、制远志粉、当归粉混合均匀后,加入到中药材总重量比例为1:10浓度为75%v/v的酒精中,常温浸泡12天,滤取浸泡酒精液保存备用,滤渣备用;(3)取酸枣仁粉、柏子仁粉混合均匀后,加入到中药材总重量比例为1:10浓度为99%v/v的酒精中,常温浸泡12天,浸泡期间每天搅拌一次,浸泡结束后,滤取酒精浸泡液保存备用,滤渣备用;(4)将步骤(2)和(3)所得酒精浸泡液分别回收酒精后,得浓缩液混合备用;(5)将步骤(2)和(3)中的滤渣合并,加入原材料重量比例为1:10的水,混合均匀,加热煮沸2小时,滤取煎煮液,将药渣再加入原药材重量比例为1:8的水,加热煮沸1.5小时,滤取煎煮液,弃去滤渣;(6)将步骤(5)两次煎煮液合并,经过滤,浓缩,浓缩至比重至5.0得浓缩液备用;(7)将步骤(6)所得浓缩液与步骤(4)所得混合浓缩液合并,按中药材等重量份加入环糊精,置于球磨机内充分研磨2.5小时,研磨结束后,取出物料,经干燥至含水量在5-6%/w、碾碎,过80目筛,即得复方灵芝提取物组合物。
3.一种复方灵芝提取物组合物的制备方法,其特征在于,它是由以下重量份的中药原料灵芝10.5份,首乌藤6.5份,制远志8.5份,当归6.5份,酸枣仁10.5份,柏子仁6.5份和与中药材原料等重量份的环糊精制成,
其制备方法如下:(1)首先分别将中药材灵芝、首乌藤、制远志、当归、酸枣仁、柏子仁进行烘干,称取灵芝、首乌藤、制远志、当归粉碎成50目粉,称取酸枣仁、柏子仁粉碎成80目粉备用;(2)将灵芝粉、首乌藤粉、制远志粉、当归粉混合均匀后,加入到中药材总重量比例为1:10浓度为75%v/v的酒精中,常温浸泡12天,滤取浸泡酒精液保存备用,滤渣备用;(3)取酸枣仁粉、柏子仁粉混合均匀后,加入到中药材总重量比例为1:10浓度为99%v/v的酒精中,常温浸泡12天,浸泡期间每天搅拌一次,浸泡结束后,滤取酒精浸泡液保存备用,滤渣备用;(4)将步骤(2)和(3)所得酒精浸泡液分别回收酒精后,得浓缩液混合备用;(5)将步骤(2)和(3)中的滤渣合并,加入原材料重量比例为1:10的水,混合均匀,加热煮沸2小时,滤取煎煮液,将药渣再加入原药材重量比例为1:8的水,加热煮沸1.5小时,滤取煎煮液,弃去滤渣;(6)将步骤(5)两次煎煮液合并,经过滤,浓缩,浓缩至比重至5.0得浓缩液备用;(7)将步骤(6)所得浓缩液与步骤(4)所得混合浓缩液合并,按中药材等重量份加入环糊精,置于球磨机内充分研磨2.5小时,研磨结束后,取出物料,经干燥至含水量在5-6%/w、碾碎,过80目筛,即得复方灵芝提取物组合物。
4.根据权利要求1-3所述的方法,其特征在于,所述的环糊精(CYD)为β-环糊精(β-CYD)、2,6-二甲基-β-环糊精(DM-β--CYD)、羟乙基-β-环糊精(HE-β-CYD)、羟丙基-β-环糊精(HP-β-CYD)和磺丁基醚-β-环糊精(SBE-β-CYD)中的任意一种。
5.根据权利要求1-3所述的方法,其特征在于,所述的酒精为食用级酒精;所述的水为纯净水。
6.根据权利要求1-3所述的方法,其特征在于,所述的干燥为真空干燥;所述真空干燥的条件为温度50℃、真空度0.2kPa。
7.根据权利要求1-3所述复方灵芝提取物组合物的用途,其特征在于,按常规工艺制成片剂、胶囊剂、颗粒剂、丸剂或口服液作为制备功能性食品的用途。
8.根据权利要求1-3所述复方灵芝提取物组合物的用途,其特征在于,作为制备成酒品的用途。
9.根据权利要求7所述的用途,其特征在于,所述的片剂为泡腾片、咀嚼片和口含片;所述的胶囊剂为软胶囊剂和硬胶囊剂;所述的丸剂为水泛丸、滴丸、微丸和蜜丸。
10.根据权利要求8所述的用途,其特征在于,所述的酒为白酒、葡萄酒、黄酒和啤酒。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910407813.5A CN110101753A (zh) | 2019-05-16 | 2019-05-16 | 一种复方灵芝提取物组合物的制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910407813.5A CN110101753A (zh) | 2019-05-16 | 2019-05-16 | 一种复方灵芝提取物组合物的制备方法和用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110101753A true CN110101753A (zh) | 2019-08-09 |
Family
ID=67490483
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910407813.5A Withdrawn CN110101753A (zh) | 2019-05-16 | 2019-05-16 | 一种复方灵芝提取物组合物的制备方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110101753A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115192668A (zh) * | 2022-09-15 | 2022-10-18 | 江中药业股份有限公司 | 一种灵芝复方提取物及其制备方法和应用 |
-
2019
- 2019-05-16 CN CN201910407813.5A patent/CN110101753A/zh not_active Withdrawn
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115192668A (zh) * | 2022-09-15 | 2022-10-18 | 江中药业股份有限公司 | 一种灵芝复方提取物及其制备方法和应用 |
CN115192668B (zh) * | 2022-09-15 | 2022-12-13 | 江中药业股份有限公司 | 一种灵芝复方提取物及其制备方法和应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110038085A (zh) | 一种复方酸枣仁组合提取物的制备方法和用途 | |
CN110613134B (zh) | 具有降血糖功能的保健食品及其制备方法 | |
CN111840394B (zh) | 一种用于失眠的药物组合物及其制备方法 | |
CN109619329A (zh) | 一种黄芪组合物及由其制备的黄芪饮料及其制备方法 | |
CN116370556B (zh) | 一种活血祛瘀、益气安神的中药组合物及其制备方法 | |
CN108813501A (zh) | 具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏 | |
CN100493578C (zh) | 一种治疗体形消瘦、体质虚弱的中药组合物及其制备方法 | |
CN110101753A (zh) | 一种复方灵芝提取物组合物的制备方法和用途 | |
CN104225295B (zh) | 用于改善睡眠的组合物及其制备方法和应用 | |
CN101190250B (zh) | 一种防治高原病的咀嚼片及其制备方法 | |
CN105796845A (zh) | 药物组合物在制备治疗女性更年期综合征药物中的用途 | |
WO2023100764A1 (ja) | 気虚及び/又は血虚に関連する症状の予防、改善又は緩和のための組成物 | |
CN104938727A (zh) | 一种抗失眠代用茶的制备方法 | |
CN105535587A (zh) | 一种治疗心肾不交型心悸失眠的中药制剂及其制备方法 | |
CN106361976A (zh) | 一种安神助眠养颜复方制剂及其制备方法 | |
CN102228596B (zh) | 一种药物组合物及制剂及在治疗冠心病、心绞痛中的应用 | |
CN110179931A (zh) | 一种养心安神组合物及其制备方法 | |
CN102485263B (zh) | 一种治疗小儿久咳的药物组合物及制备方法 | |
CN101015596A (zh) | 一种用于治疗心脑血管疾病的中成药及其制备方法 | |
CN104920742A (zh) | 一种抗失眠代用茶 | |
CN105726947B (zh) | 一种改善睡眠、降血糖的刺五加叶玉竹叶提取物及其制备方法和用途 | |
CN107595870A (zh) | 一种健脑安神的药物组合物、药物制剂及应用和制备方法 | |
CN110025721A (zh) | 一种复方胖大海组合提取物的制备方法和用途 | |
CN105560984B (zh) | 一种益气健脾的中药组合物 | |
CN107753628A (zh) | 一种治疗失眠的中药组合物及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20190809 |
|
WW01 | Invention patent application withdrawn after publication |